Effect of growth hormone on small intestinal homeostasis relation to cellular mediators IGF-I and IGFBP-3

World Journal of Gastroenterology

Volumn 15, Issue 43, 2009, Pages 5418-5424

  Ersoy, Betul ^a   Ozbilgin, Kemal ^a   Kasirga, Erhun ^a   Inan, Sevinc ^a   Coskun, Senol ^a   Tuglu, Ibrahim ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

Growth hormone; Insulin like growth factor binding protein 3; Like growth factor 1; Small intestine

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE; PLACEBO; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CRYPT CELL; DRUG MECHANISM; ENTEROENDOCRINE CELL; GOBLET CELL; HISTOLOGY; HOMEOSTASIS; HUMAN; IMMUNOREACTIVITY; INTESTINE FUNCTION; INTESTINE VILLUS; JEJUNUM; MALE; MICROSCOPY; MORPHOMETRICS; NONHUMAN; PERIODIC ACID SCHIFF STAIN; RAT; SMALL INTESTINE; STAINING;

EID: 74249123638     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.5418     Document Type: Article

References (37)

1. Choi HK, Waxman DJ. Pulsatility of growth hormone (GH) signalling in liver cells: role of the JAK-STAT5b pathway in GH action. Growth Horm IGF Res 2000; 10 Suppl B: S1-S8
2. Lobie PE, Breipohl W, Lincoln DT, Garcia-Aragon J, Waters MJ. Localization of the growth hormone receptor/binding protein in skin. J Endocrinol 1990; 126: 467-471
3. Lund PK. Molecular basis of intestinal adaptation: the role of the insulin-like growth factor system. Ann N Y Acad Sci 1998; 859: 18-36
4. Theiss AL, Fruchtman S, Lund PK. Growth factors in inflammatory bowel disease: the actions and interactions of growth hormone and insulin-like growth factor-I. Inflamm Bowel Dis 2004; 10: 871-880
5. Wheeler EE, Challacombe DN. The trophic action of growth hormone, insulin-like growth factor-I, and insulin on human duodenal mucosa cultured in vitro. Gut 1997; 40: 57-60
6. Clemens DR. Insulin-like growth factor-1 and its binding proteins. In: DeGroot LJ, editor. Pediatric Endocrinology, 3rd ed. Philedelphia: WB Saunders, 2000: 439-460
7. Hansson HA, Nilsson A, Isgaard J, Billig H, Isaksson O, Skottner A, Andersson IK, Rozell B. Immunohistochemical localization of insulin-like growth factor I in the adult rat. Histochemistry 1988; 89: 403-410
8. Ryan J, Costigan DC. Determination of the histological distribution of insulin like growth factor 1 receptors in the rat gut. Gut 1993; 34: 1693-1697
9. Baksheev L, Fuller PJ. Humoral factors in intestinal adaptation. Trends Endocrinol Metab 2000; 11: 401-405
10. Gomez de Segura IA, Aguilera MJ, Codesal J, Codoceo R, De-Miguel E. Comparative effects of growth hormone in large and small bowel resection in the rat. J Surg Res 1996; 62: 5-10
11. Gingerich RL, Gilbert WR, Comens PG, Gavin JR 3rd. Identification and characterization of insulin receptors in basolateral membranes of dog intestinal mucosa. Diabetes 1987; 36: 1124-1129
12. Glasscock GF, Gelber SE, Lamson G, McGee-Tekula R, Rosenfeld RG. Pituitary control of growth in the neonatal rat: effects of neonatal hypophysectomy on somatic and organ growth, serum insulin-like growth factors (IGF)-I and -II levels, and expression of IGF binding proteins. Endocrinology 1990; 127: 1792-1803
13. Daughaday WH, Hall K, Raben MS, Salmon WD Jr, van den Brande JL, van Wyk JJ. Somatomedin: proposed designation for sulphation factor. Nature 1972; 235: 107
14. Beauchamp RD, Barnard JA, McCutchen CM, Cherner JA, Coffey RJ Jr. Localization of transforming growth factor alpha and its receptor in gastric mucosal cells. Implications for a regulatory role in acid secretion and mucosal renewal. J Clin Invest 1989; 84: 1017-1023
15. Zhao J, Yang J, Vinter-Jensen L, Zhuang F, Gregersen H. The morphometry and biomechanical properties of the rat small intestine after systemic treatment with epidermal growth factor. Biorheology 2002; 39: 719-733
16. Budwit-Novotny DA, McCarty KS, Cox EB, Soper JT, Mutch DG, Creasman WT, Flowers JL, McCarty KS Jr. Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res 1986; 46: 5419-5425
17. Heeckt PF, Klein D, Beger HG. Short-bowel syndrome - surgical treatment with long-term benefit? Langenbecks Arch Surg 2000; 385: 50-56
18. Challacombe DN, Wheeler EE. The trophic action of human growth hormone on human duodenal mucosa cultured in vitro. J Pediatr Gastroenterol Nutr 1995; 21: 50-53
19. Beer VJ, Warren MA, Cope GH, Baillie HS. Effects of growth hormone on intestinal morphology of genetically dwarf rats. J Anat 1995; 186 (Pt 2): 253-259
20. Szkudlarek J, Jeppesen PB, Mortensen PB. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomised, double blind, crossover, placebo controlled study. Gut 2000; 47: 199-205
21. Byrne TA, Persinger RL, Young LS, Ziegler TR, Wilmore DW. A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet. Ann Surg 1995; 222: 243-254; discussion 254-255
22. Wilmore DW, Lacey JM, Soultanakis RP, Bosch RL, Byrne TA. Factors predicting a successful outcome after pharmacologic bowel compensation. Ann Surg 1997; 226: 288-292; discussion 292-293
23. Scolapio JS, Camilleri M, Fleming CR, Oenning LV, Burton DD, Sebo TJ, Batts KP, Kelly DG. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology 1997; 113: 1074-1081
24. Deplancke B, Gaskins HR. Microbial modulation of innate defense: goblet cells and the intestinal mucus layer. Am J Clin Nutr 2001; 73: 1131S-1141S
25. Gaudier E, Forestier L, Gouyer V, Huet G, Julien R, Hoebler C. Butyrate regulation of glycosylation-related gene expression: evidence for galectin-1 upregulation in human intestinal epithelial goblet cells. Biochem Biophys Res Commun 2004; 325: 1044-1051
26. Raguso CA, Leverve X, Pichard C. Protective effects of recombinant growth hormone on intestinal mucosa in rats receiving abdominal radiotherapy. Clin Nutr 2002; 21: 487-490
27. Le Roith D, Scavo L, Butler A. What is the role of circulating IGF-I? Trends Endocrinol Metab 2001; 12: 48-52
28. Chen K. Insulin-like growth factor 1 enhances mucosal adaptation after jejunoileal rejection. Gastroenterology 1999; 102: 1949-1956
29. Ohneda K, Ulshen MH, Fuller CR, D'Ercole AJ, Lund PK. Enhanced growth of small bowel in transgenic mice expressing human insulin-like growth factor I. Gastroenterology 1997; 112: 444-454
30. Sigalet DL, Martin GR. Hormonal therapy for short bowel syndrome. J Pediatr Surg 2000; 35: 360-363; discussion 364
31. Canani RB, Bisceglia M, Bruzzese E, Mallardo G, Guarino A. Growth hormone stimulates, through tyrosine kinase, ion transport and proliferation in human intestinal cells. J Pediatr Gastroenterol Nutr 1999; 28: 315-320
32. Judge TA, Lichtenstein GR. Novel medical therapies for crohn's disease: is there room for growth? Gastroenterology 2001; 120: 308-311
33. Coppola D, Ferber A, Miura M, Sell C, D'Ambrosio C, Rubin R, Baserga R. A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor. Mol Cell Biol 1994; 14: 4588-4595
34. DeAngelis T, Ferber A, Baserga R. Insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the platelet-derived growth factor receptor. J Cell Physiol 1995; 164: 214-221
35. Gu Y, Wu ZH. The anabolic effects of recombinant human growth hormone and glutamine on parenterally fed, short bowel rats. World J Gastroenterol 2002; 8: 752-757
36. Blum WF, Albertsson-Wikland K, Rosberg S, Ranke MB. Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Metab 1993; 76: 1610-1616
37. Ney DM. Effects of insulin-like growth factor-I and growth hormone in models of parenteral nutrition. JPEN J Parenter Enteral Nutr 1999; 23: S184-S189